Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous mesenchymal stem cells (1 trial)
cefazolin (ancef) (1 trial)
polyethylene glycol (1 trial)
Amyotrophic Lateral Sclerosis (Phase 2)
Motor Neuron Disease (Phase 2)
Sclerosis (Phase 2)
Trials (2 total)
Trial APIs (3 total)